This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
This guide flags the index funds with the lowest fees for retirement, plus tips on mitigating cost drag over time.
27,216 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
The 13F filings show billionaire david tepper goes big on Alphabet, Micron, and Meta, while dialing back on Alibaba a...
A fresh wave of billionaire investors is entering META shares amid AI spending concerns, with analysts estimating abo...
Bitcoin rose sharply after news that a five-day window for Iran talks could cool tensions, lifting broader markets. C...
Zerohash Europe becomes the first crypto firm to hold both an EMI license and MiCA authorization, expanding stablecoi...
NVIDIA's leadership and AI-driven demand are reshaping the stock market landscape. This article dives into what Jense...
Bitcoin eyes a pivotal test near the $58,000 zone as ETF-driven demand falters. If that support cracks, bitcoin still...
A Hong Kong-based firm disclosed a $436 million stake in BlackRock’s IBIT, highlighting how offshore capital channels...
Joby Aviation has moved lower after hitting a peak. This guide weighs the risks and potential catalysts, and offers a...
Ripple expands its blockchain pilot by entering Singapore's BLOOM sandbox, testing RLUSD-backed trade settlements on ...
A quiet SEC filing reveals a larger stake in Par Pacific. Explore what forest avenue capital adds means for investors...
A wave of vault-based yield services blends familiar banking interfaces with hidden DeFi vaults, reshaping access to ...